Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Insulin resistance appears to be the best predictor of the development of diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is unknown. METHODS: We performed hyperinsulinemic-euglycemic clamp studies in combination with infusions of [6,6-(2)H(2)]glucose in healthy, young, lean, insulin-resistant offspring of patients with type 2 diabetes and insulin-sensitive control subjects matched for age, height, weight, and physical activity to assess the sensitivity of liver and muscle to insulin. Proton ((1)H) magnetic resonance spectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride content. Rates of whole-body and subcutaneous fat lipolysis were assessed by measuring the rates of [(2)H(5)]glycerol turnover in combination with microdialysis measurements of glycerol release from subcutaneous fat. We performed (31)P magnetic resonance spectroscopy studies to assess the rates of mitochondrial oxidative-phosphorylation activity in muscle. RESULTS: The insulin-stimulated rate of glucose uptake by muscle was approximately 60 percent lower in the insulin-resistant subjects than in the insulin-sensitive control subjects (P<0.001) and was associated with an increase of approximately 80 percent in the intramyocellular lipid content (P=0.005). This increase in intramyocellular lipid content was most likely attributable to mitochondrial dysfunction, as reflected by a reduction of approximately 30 percent in mitochondrial phosphorylation (P=0.01 for the comparison with controls), since there were no significant differences in systemic or localized rates of lipolysis or plasma concentrations of tumor necrosis factor alpha, interleukin-6, resistin, or adiponectin. CONCLUSIONS: These data support the hypothesis that insulin resistance in the skeletal muscle of insulin-resistant offspring of patients with type 2 diabetes is associated with dysregulation of intramyocellular fatty acid metabolism, possibly because of an inherited defect in mitochondrial oxidative phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [2]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is based on the finding that type 2 diabetics and insulin-resistant individuals with impaired glucose tolerance have ≈30% less mitochondria in their muscles than insulin-sensitive control subjects (3–7).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, lean healthy offspring of diabetic parents have a significant decrease in insulin-stimulated total body and muscle glucose disposal which is of a similar magnitude to that observed in their diabetic parents [30–32].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis is supported by in vivo reports that the incorporation of 13 C-acetate into glutamate and mitochondrial phosphorylation was approximately 30% lower in muscle of insulin-resistant versus lean individuals (81,83).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that insulin resistance is strongly associated with increases in hepatic (HTG) and ∕ or intramyocellular lipid content”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [11]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Research works printed but not linked: 1
- Luft R, Luthman H. Mitokondriernas patofysiologi: från Lufts sjukdom till åldrande och diabetes. Lakartidningen. 1993;90:2770–5. [PubMed] [Google Scholar]
Cited by
Items 501–600 of 1,020
Lo, J., Bernstein, L. E., Canavan, B., Torriani, M., Jackson, M. B., Ahima, R. S., & Grinspoon, S. K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2007 · Cited by 106
Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes
Cnop, M., Igoillo‐Esteve, M., Rai, M., Begu, A., Serroukh, Y., Depondt, C., Musuaya, A. E., Marhfour, I., Ladrière, L., Moles Lopez, X., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23698 · Cited by 97
“Using (31)P magnetic resonance spectroscopy, impaired muscular mitochondrial function was demonstrated in vivo in FRDA patients,(27,28) similar to findings in insulin-resistant offspring of T2D patients.(29) Heterozygous carriers were also reported to be insulin resistant,(30) and intermediate GAA repeat length has be…”
ResultLeite, S. A. O., Monk, A. M., Upham, P. A., Chacra, A. R., & Bergenstal, R. M. (2009) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-1-8 · Cited by 127
“An early step in the development of insulin resistance in offspring of patients with type 2 diabetes is impaired mitochondrial activity [24].”
BackgroundJin, W., Goldfine, A. B., Boes, T., Henry, R. R., Ciaraldi, T. P., Kim, E.-Y., Emecan, M., Fitzpatrick, C., Sen, A., Shah, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41940 · Cited by 106
Meat Consumption as a Risk Factor for Type 2 Diabetes
Barnard, N., Levin, S., & Trapp, C. (2014) · Nutrients · doi:10.3390/nu6020897 · Cited by 91
“Studies have suggested that fat accumulation within muscle and liver cells (or the metabolism of these lipids) aggravates insulin resistance which, in turn, contributes to type 2 diabetes [28–30].”
BackgroundUpdating the effects of fatty acids on skeletal muscle
Silveira, L. R., Fiamoncini, J., Hirabara, S. M., Procópio, J., Cambiaghi, T. D., Pinheiro, C. H. J., Lopes, L. R., & Curi, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21514 · Cited by 104
“As a result, IRS-1 association with phosphatidylinositol-3-kinase (PI3-kinase) is impaired reducing the insulin-stimulated translocation of the glucose transporter, GLUT-4, to plasma membrane (Petersen et al., 2004).”
BackgroundInfluentialLKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training
Sriwijitkamol, A., Ivy, J. L., Christ-Roberts, C., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00429.2005 · Cited by 103
“Research suggests that abnormal mitochondrial function can impair insulin action and result in insulin resistance in human muscle (33, 41, 42).”
BackgroundKoeck, T., Olsson, A. H., Nitert, M. D., Sharoyko, V. V., Ladenvall, C., Kotova, O., Reiling, E., Rönn, T., Parikh, H., Taneera, J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.007 · Cited by 105
Kizhakekuttu, T. J., Wang, J., Dharmashankar, K., Ying, R., Gutterman, D. D., Vita, J. A., & Widlansky, M. E. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.256024 · Cited by 105
“2531 The worldwide incidence of type 2 diabetes mellitus (T2DM) is expected to exceed 350 million people in 2030, with the incidence rate of T2DM increasing in all segments of the population.1,2 The majority of morbidity and mortality related to diabetes mellitus is secondary to the macrovascular (myocardial infarctio…”
BackgroundInfluentialImpaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss
Corpeleijn, E., Mensink, M., Kooi, M. E., Roekaerts, P. M. H. J., Saris, W. H. M., & Blaak, E. E. (2008) · Obesity · doi:10.1038/oby.2008.24 · Cited by 104
SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity
Rutanen, J., Yaluri, N., Modi, S., Pihlajamäki, J., Vänttinen, M., Itkonen, P., Kainulainen, S., Yamamoto, H., Lagouge, M., Sinclair, D. A., et al. (2010) · Diabetes · doi:10.2337/db09-1191 · Cited by 104
“The offspring of type 2 diabetic subjects are known to be insulin resistant, and they have defects in mitochondrial OXPHOS associated with increased intramyocellular lipid content (9).”
BackgroundHurvitz, E. A., Green, L. B., Hornyak, J. E., Khurana, S. R., & Koch, L. G. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181617736 · Cited by 102
“primary determinant of the complex features of metabolic syndrome.(37,38) In addition, several recent findings have emphasized the role of mitochondrial dysfunction in many neurological disorders with oxidative mechanisms of injury such as the hypoxic–ischemic injury mechanism to developing oligodendrocytes proposed f…”
BackgroundThe challenges of gene expression microarrays for the study of human cancer
Tinker, A. V., Boussioutas, A., & Bowtell, D. D. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.001 · Cited by 109
“The results were felt to be biologically plausible and have since been independently validated (Patti et al., 2003; Petersen et al., 2004).”
Misu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0489-8 · Cited by 102
“This reduction is related to impaired oxidative capacity and accumulation of triacylglycerol in the skeletal muscle, which correlates with insulin resistance [5].”
BackgroundMitochondrial metabolism and diabetes
Kwak, S. H., Park, K. S., Lee, K., & Lee, H. K. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00047.x · Cited by 112
Fat distribution and storage: how much, where, and how?
Weiss, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0125 · Cited by 101
Ørtenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., & Gaster, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.001 · Cited by 101
“[8] have provided evidence for a possible inherited defect in mitochondrial oxidative phosphorylation in the skeletal muscle of insulin-resistant offspring of patients with T2D, which was associated with dysregulation of intracellular fatty acid metabolism.”
BackgroundGreen, C. L., Pak, H. H., Richardson, N. E., Flores, V., Yu, D., Tomasiewicz, J. L., Dumas, S. N., Kredell, K., Fan, J. W., Kirsh, C., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.018 · Cited by 105
Fadool, D. A., Tucker, K., & Pedarzani, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024921 · Cited by 99
“[33] have determined the relationship between capillary density and cellular metabolism, with fine spatial resolution in the olfactory bulb.”
BackgroundVasudevan, A. R., & Balasubramanyam, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.850 · Cited by 110
Perioperative diabetic and hyperglycemic management issues
Coursin, D. B., Connery, L. E., & Ketzler, J. T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000115623.52021.c0 · Cited by 109
Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome
Lim, S. K., Cho, Y. M., Park, K. S., & Lee, H. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05622.x · Cited by 104
The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
Yi, H.-S., Chang, J. Y., & Shong, M. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0005 · Cited by 99
High Oxidative Capacity Due to Chronic Exercise Training Attenuates Lipid-Induced Insulin Resistance
Phielix, E., Meex, R., Ouwens, D. M., Sparks, L., Hoeks, J., Schaart, G., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2012) · Diabetes · doi:10.2337/db11-1832 · Cited by 99
Cnop, M., Mulder, H., & Igoillo‐Esteve, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12216 · Cited by 117
“On one hand, aging and physical inactivity both are major risk factors for insulin resistance and type 2 diabetes as well as major determinants of mitochondrial function and mass (Petersen et al. 2004).”
BackgroundHaidar, A., Yassin, A., Saad, F., & Shabsigh, R. (2007) · The Aging Male · doi:10.1080/13685530701653538 · Cited by 100
“Recent studies using genetic analysis [31,32], or functional imaging [33,34], have shed light on the role of mitochondrial function in inducing metabolic disturbances characteristic of insulin resistance.”
BackgroundSchrauwen, P., Hoeks, J., & Hesselink, M. K. C. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.001 · Cited by 111
Statins are associated with increased insulin resistance and secretion
Abbasi, F., Lamendola, C., Harris, C. S., Harris, V., Tsai, M.-S., Tripathi, P., Abbas, F., Reaven, G. M., Reaven, P. D., Snyder, M. P., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316159 · Cited by 98
Morrow, R. M., Picard, M., Derbeneva, O., Leipzig, J., McManus, M. J., Gouspillou, G., Barbat-Artigas, S., Dos Santos, C., Hepple, R. T., Murdock, D. G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700997114 · Cited by 96
Trenell, M. I., Ward, J. A., Yee, B. J., Phillips, C. L., Kemp, G. J., Grunstein, R. R., & Thompson, C. H. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00649.x · Cited by 99
Kulkarni, S. S., Salehzadeh, F., Fritz, T., Zierath, J. R., Krook, A., & Osler, M. E. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.014 · Cited by 110
Tumor Necrosis Factor-α Modulates Human in Vivo Lipolysis
Plomgaard, P., Fischer, C. P., Ibfelt, T., Pedersen, B. K., & van Hall, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1761 · Cited by 97
Sud, N., Wells, S. M., Sharma, S., Wiseman, D. A., Wilham, J. M., & Black, S. M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00384.2007 · Cited by 101
“Disruption of mitochondrial function is acknowledged as a critical event in a number of pathological conditions, including hypoxia-ischemic injuries (3), stroke (56), and diabetes (17, 39, 41, 44).”
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Arenillas, J. F., Moro, M. Á., & Dávalos, A. (2007) · Stroke · doi:10.1161/strokeaha.106.480004 · Cited by 111
Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients
Takamura, T., Misu, H., Matsuzawa‐Nagata, N., Sakurai, M., Ota, T., Shimizu, A., Kurita, S., Takeshita, Y., Ando, H., Honda, M., et al. (2008) · Obesity · doi:10.1038/oby.2008.419 · Cited by 96
“We did not observe a similar effect of obesity on hepatic gene expression involved in the OXPHOS pathway in nondiabetic subjects (data not shown), suggesting that mitochondrial dysfunction has an important role in the pathophysiology of type 2 diabetes, as reported previously (18).”
BackgroundMitochondrial dysfunction in patients with primary congenital insulin resistance
Sleigh, A., Raymond-Barker, P., Thackray, K., Porter, D., Hatunic, M., Vottero, A., Burren, C., Mitchell, C., McIntyre, M., Brage, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46405 · Cited by 96
Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver
Takamura, T., Misu, H., Ota, T., & Kaneko, S. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0228 · Cited by 96
Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells
Contreras-Shannon, V., Heart, D. L., Paredes, R. M., Navaira, E., Catano, G., Maffi, S. K., & Walss‐Bass, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059012 · Cited by 104
“In these patients, electron transport [30] and oxidative phosphorylation [31,32] are altered.”
BackgroundVankoningsloo, S., De Pauw, A., Houbion, A., Tejerina, S., Demazy, C., de Longueville, F., Bertholet, V., Renard, P., Remacle, J., Holvoet, P., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.02848 · Cited by 97
“…experimental models now clearly support a direct link between mitochondrial dysfunction and metabolic disorders, therefore addressing the essential role of mitochondrial-activity impairment in alterations in lipid metabolism (Lowell and Shulman, 2005; Petersen et al., 2003; Petersen et al., 2004).”
Civitarese, A. E., MacLean, P. S., Carling, S., Kerr-Bayles, L., McMillan, R. P., Pierce, A., Becker, T. C., Moro, C., Finlayson, J., Lefort, N., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.004 · Cited by 95
“, 2007), and elevated reactive oxygen species (ROS) production (Civitarese et al., 2006; Patti et al., 2003; Petersen et al., 2004; Ukropcova et al., 2007).”
InfluentialMitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment
Clemente‐Suárez, V. J., Martín-Rodríguez, A., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108848 · Cited by 108
“Mitochondrial dysfunction in T2DM is characterized by decreased mitochondrial content and impaired mitochondrial function, which can contribute to insulin resistance and impaired glucose metabolism [17].”
BackgroundMuscle mitochondria and insulin resistance: a human perspective
Hoeks, J., & Schrauwen, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.007 · Cited by 94
Finocchietto, P. V., Franco, M. C., Holod, S., Gonzalez, A. S., Converso, D. P., Arciuch, V. G. A., Serra, M. P., Poderoso, J. J., & Carreras, M. C. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-81 · Cited by 93
“It was recently reported that in the metabolic syndrome with hyperinsulinemia, mitochondrial dysfunction facilitates muscle fat accumulation (61) and accelerates its progression.”
BackgroundAwad, S., Constantin‐Teodosiu, D., Macdonald, I. A., & Lobo, D. N. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.014 · Cited by 102
Hypercatabolic Syndrome: Molecular Basis and Effects of Nutritional Supplements with Amino Acids
Pasini, E., Aquilani, R., Dioguardi, F. S., D’Antona, G., Gheorghiade, M., & Taegtmeyer, H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.074 · Cited by 102
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 91
“…et al., 2002; Morino et al., 2005; Ritov et al., 2005), decreased ATP synthesis in insulin resistant offspring of patients with type 2 diabetes (Petersen et al., 2004, 2005) and decreased maximal respiration rates in skeletal muscle isolated mitochondria from type 2 diabetics (Mogensen et al.,…”
BackgroundMitochondrial dysfunction and its impact on diabetic heart
Verma, S. K., Garikipati, V. N. S., & Kishore, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.021 · Cited by 99
“resistant offspring of Type 2 diabetes [53, 54].”
Timmers, S., Hesselink, M. K. C., & Schrauwen, P. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12185 · Cited by 93
Petersen, K. F., Dufour, S., Morino, K., Yoo, P. S., Cline, G. W., & Shulman, G. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205675109 · Cited by 90
“At 7:00 AM one of the subject’s hands was placed in a heated box and warmed to 55 °C (to “arterialize” the venous blood) and a polyethylene catheter was inserted retrogradely into one of the hand veins for blood collections (11).”
BackgroundMethodSelf-citationTargeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 101
Pulmonary Function and Sleep Breathing: Two New Targets for Type 2 Diabetes Care
Lecube, A., Simó, R., Pallayová, M., Punjabi, N. M., López‐Cano, C., Turino, C., Hernández, C., & Barbé, F. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00173 · Cited by 101
Mitochondrial function in ageing: coordination with signalling and transcriptional pathways
Yin, F., Sancheti, H., Liu, Z., & Cadenas, E. (2016) · The Journal of Physiology · doi:10.1113/jp270541 · Cited by 90
“It is well known that the mitochondrial function is impaired during insulin resistance (Petersen et al. 2004; Lowell & Shulman, 2005; Parish & Petersen, 2005; Højlund et al. 2008).”
BackgroundInfluentialLiu, H.-Y., Cao, S. Y., Hong, T., Han, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016675 · Cited by 91
Role of autophagy in diabetes and mitochondria
Jung, H. S., & Lee, M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05614.x · Cited by 92
Mitochondria and Diabetes. An Intriguing Pathogenetic Role
Newsholme, P., Gaudel, C., & Krause, M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_10 · Cited by 105
“Impaired basal and insulin-stimulated mitochondrial metabolism in vivo was also demonstrated in patients with type-2 diabetes (Schrauwen-Hinderling et al. 2007 ) and fi rst-degree relatives of type-2 diabetes patients (Petersen et al. 2004 ; Befroy et al. 2007 ) .”
BackgroundHafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91
Oh, D. Y., & Lagakos, W. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283479230 · Cited by 100
Coletta, D. K., & Mandarino, L. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00363.2011 · Cited by 90
“More recently, lower insulin action has been associated with reduced content, and perhaps elements of function, of mitochondria in skeletal muscle that has more characteristics of fast-twitch, glycolytic, type II muscle fibers (11, 26, 46).”
BackgroundFerreira, H. B., Melo, T., Paiva, A. A., & Domingues, M. R. (2021) · Antioxidants · doi:10.3390/antiox10010045 · Cited by 100
“Inflammation and insulin resistance are correlated with diminished mitochondrial function and content, thus disrupting muscle oxidative metabolic capacity and increasing levels of intramyocellular lipid content [26,27].”
BackgroundGilbert, M. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13614 · Cited by 97
Jaiswal, N., Maurya, C. K., Arha, D., Avisetti, D. R., Ayyappan, P., Raj, P. S., Raghu, K. G., Kalivendi, S. V., & Tamrakar, A. K. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1128-y · Cited by 100
Schlernitzauer, A., Oiry, C., Hamad, R., Galas, S., Cortade, F., Chabi, B., Casas, F., Pessemesse, L., Fouret, G., Feillet‐Coudray, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078788 · Cited by 96
“As a decrease in mitochondrial mass and activity has been reported in insulin resistant or type 2 diabetic patients [60,61], and because mitochondrial deficiency impaired the insulin pathway through cellular fatty acid accumulation [62], it has been proposed that increasing mitochondrial mass in muscle could be an eff…”
BackgroundMcMackin, C. J., Widlansky, M. E., Hamburg, N. M., Huang, A. L., Weller, S., HOLBROOK, M. M., Gokce, N., Hagen, T. M., Keaney, J. F., & Vita, J. A. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06052.x · Cited by 100
Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects
Hippe, B., Remely, M., Aumueller, E., Pointner, A., Magnet, U., & Haslberger, A. G. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0075 · Cited by 86
“Moderate butyrate levels can prevent high fat-diet induced insulin insensitivity due to epigenetic regulation, increasing the mitochondrial beta oxidation, and acts so to improve glucose sensitivity and adiposity (Petersen et al., 2004).”
Leucine in Obesity: Therapeutic Prospects
Yao, K., Duan, Y., Li, F., Tan, B., Hou, Y., Wu, G., & Yin, Y. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.004 · Cited by 99
“Mitochondrial dysfunction involves a lower content and presumably reduced functionality of mitochondria, as evidenced by reduced fatty acid oxidation activity and high lipid content in adipose tissue, muscle, and liver [46,47].”
BackgroundCPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
Sebastián, D., Herrero, L., Serra, D., Asins, G., & Hegardt, F. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2006 · Cited by 89
“Insulin resistance is associated with a decreased mitochondrial number, unusual morphology, lower levels of mitochondrial oxidative enzymes, and lower ATP synthesis in both in vivo studies in humans (25, 43) and ex vivo human muscle biopsies (18, 26, 52).”
BackgroundSzymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 101
“T2DM patients are characterized by decreased numbers of mitochondria, resulting in diminished cellular respiration efficacy in the liver, and mitochondrial dysfunction is suggested as one of factors associated with T2DM development [45].”
BackgroundHirahatake, K. M., Slavin, J. L., Maki, K. C., & Adams, S. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.009 · Cited by 86
Sharma, S., Sud, N., Wiseman, D. A., Carter, A. L., Kumar, S., Hou, Y., Rau, T., Wilham, J. M., Harmon, C., Oishi, P. E., et al. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00247.2007 · Cited by 89
“Disruption of mitochondrial function is a critical event in a number of pathological conditions, including hypoxia-ischemic injuries (6), stroke (59), and diabetes (16, 45, 47, 50).”
BackgroundØstergård, T., Andersen, J. L., Nyholm, B., Lund, S., Nair, K. S., Saltin, B., & Schmitz, O. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00012.2005 · Cited by 88
“Others (29) have more specifically examined insulin-resistant offspring, e.”
BackgroundResultInfluentialExercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.006 · Cited by 101
Puchałowicz, K., & Rać, M. E. (2020) · Cells · doi:10.3390/cells9081877 · Cited by 97
Bell, J. A., Reed, M. A., Consitt, L. A., Martin, O. J., Haynie, K. R., Hulver, M. W., Muoio, D. M., & Dohm, G. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1596 · Cited by 87
Avital, G., Buchshtav, M., Zhidkov, I., Tuval, J., Dadon, S., Rubin, E., Glass, D., Spector, T. D., & Mishmar, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds245 · Cited by 94
“Second, offspring of T2DM patients who had not developed the disease showed reduced ATP production (12).”
BackgroundPetersen, K. F., & Shulman, G. I. (2006) · Obesity · doi:10.1038/oby.2006.280 · Cited by 87
“In more recent studies, using the same (31)P MRS techniques to assess rates of ATP synthesis in skeletal muscle, we found similar reductions in mitochondrial activity associated with an increase in intramyocellular lipid content in young, lean, insulin-resistant offspring of parents with type 2 diabetes, a group that…”
BackgroundSelf-citationThyfault, J. P., Cree, M. G., Zheng, D., Zwetsloot, J. J., Tapscott, E. B., Koves, T. R., Ilkayeva, O., Wolfe, R. R., Muoio, D. M., & Dohm, G. L. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00311.2006 · Cited by 87
“For example, several studies (27, 36, 37) have shown that humans with peripheral insulin resistance, type II diabetes, and C737 MUSCLE CONTRACTION AND INSULIN RESISTANCE”
BackgroundResultA review on linking stress, depression, and insulin resistance via low-grade chronic inflammation
Mehdi, S., Wani, S. U. D., Krishna, K. L., Kinattingal, N., & Roohi, T. F. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101571 · Cited by 127
“Insulin resistance is a common symptom of most people with T2DM and one of the hallmark clinical aspects of MS [135].”
BackgroundChow, L. S., Greenlund, L. J., Asmann, Y. W., Short, K. R., McCrady, S. K., Levine, J. A., & Nair, K. S. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00791.2006 · Cited by 87
“As skeletal muscle is a major site of glucose utilization, correlational data support the hypothesis that insulin resistance is related to age-associated reductions in muscle mitochondrial function (39, 51).”
BackgroundResistance to type 2 diabetes mellitus: a matter of hormesis?
Kolb, H., & Eizirik, D. L. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.158 · Cited by 92
“Indeed, patients with T2DM demonstrate a decreased mass of mitochondria per cell, associated with reduced mitochondrial activity”
BackgroundRosiglitazone Improves Exercise Capacity in Individuals With Type 2 Diabetes
Regensteiner, J. G., Bauer, T. A., & Reusch, J. E. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2877 · Cited by 87
Piché, M.-E., Weisnagel, S. J., Corneau, L., Nadeau, A., Bergeron, J., & Lemieux, S. (2005) · Diabetes · doi:10.2337/diabetes.54.3.770 · Cited by 88
“These alterations in fatty acid metabolism may represent a mechanism by which IR could be linked to hypertriglyceridemia (46).”
BackgroundA perspective on the determination of mitochondrial biogenesis
Miller, B. F., & Hamilton, K. L. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00578.2011 · Cited by 86
Martins, A. R., Crisma, A. R., Masi, L. N., do Amaral, C. L., Marzuca-Nassr, G. N., Bomfim, L. H. M., Teodoro, B. G., Queiroz, A. L., Serdan, T. D. A., Torres, R. P., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.012 · Cited by 95
Role of oxidative stress in diabetes-induced complications and their management with antioxidants
Singh, H. B., Singh, R., Singh, A., Singh, H., Singh, G., Kaur, S., & Singh, B. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2243651 · Cited by 98
“…above-mentioned aspects, il-1β, il-6, tumour necrosis factor (tNF)-α, and cRP are worth mentioning (cagnina et al. 1999, Mandy woods et al. 1999, Petersen et al. 2004, low wang et al. 2016). in addition, it is well documented that type 2 DM is associated with enhanced platelet and haemostatic…”
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
“However, inflammatory processes do not fully explain the development of IR because no changes in inflammatory markers have been detected in subjects with T2D [197].”
Understanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 95
The ‘developmental origins’ hypothesis: epidemiology
Godfrey, K. (2006) · Developmental Origins of Health and Disease · doi:10.1017/cbo9780511544699.003 · Cited by 86
Mechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 104
Pardo, R., Enguix, N., Lasheras, J., Feliu, J. E., Kralli, A., & Villena, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026989 · Cited by 86
“Consistent with decreased gene expression, insulin-resistant offspring of patients with type 2 diabetes exhibit diminished mitochondrial oxidative capacity [8].”
BackgroundLawan, A., Min, K., Zhang, L., Canfrán‐Duque, A., Jurczak, M. J., Camporez, J. P., Nie, Y., Gavin, T. P., Shulman, G. I., Fernandez-Hernando, C. F., et al. (2018) · Diabetes · doi:10.2337/db17-0826 · Cited by 111
“the pathogenesis of insulin resistance and type 2 diabetes (9,40).”
BackgroundSelf-citationMustelin, L., Pietiläinen, K. H., Rissanen, A., Sovijärvi, A. R., Piirilä, P., Naukkarinen, J., Peltonen, L., Kaprio, J., & Yki-Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00580.2007 · Cited by 85
“4 mitochondria in insulin-resistant subjects was therefore suggested to be due to an inherited genetic defect (54).”
BackgroundInfluentialProgressive adaptation of hepatic ketogenesis in mice fed a high-fat diet
Sunny, N. E., Satapati, S., Fu, X., He, T., Mehdibeigi, R., Spring-Robinson, C., Duarte, J., Potthoff, M. J., Browning, J. D., & Burgess, S. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00033.2010 · Cited by 82
Pravenec, M., Hyakukoku, M., Houstek, J., Zidek, V., Landa, V., Mlejnek, P., Miksik, I., Dudová-Mothejzikova, K., Pecina, P., Vrbacký, M., et al. (2007) · Genome Research · doi:10.1101/gr.6548207 · Cited by 84
“Because reduced skeletal muscle glycogen synthesis is a characteristic feature of pre-diabetic individuals with suboptimal glucose tolerance and of patients with diabetes (Shulman et al. 1990; Petersen et al. 2004), we also measured glycogen content in skeletal muscle of the SHR conplastic and progenitor strains.”
BackgroundInfluentialSkeletal muscle mitochondrial capacity and insulin resistance in type 2 diabetes.
Bajpeyi, S., Pasarica, M., Moro, C., Conley, K., Jubrias, S., Sereda, O., Burk, D. H., Zhang, Z., Gupta, A., Kjems, L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1621 · Cited by 84
Reprogramming of energy metabolism as a driver of aging
Feng, Z., Hanson, R. W., Berger, N. A., & Trubitsyn, A. G. (2016) · Oncotarget · doi:10.18632/oncotarget.7645 · Cited by 89
“Type II diabetes is associated with metabolic changes paralleling the Warburg effect, including expression of genes involved in anaerobic glycolysis [64] and a decline in mitochondrial function [65].”
BackgroundRole of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 100
Toledo, F. G. S., & Goodpaster, B. H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.018 · Cited by 93
“In support of this hypothesis, signs of mitochondrial abnormalities were reported in lean healthy subjects with a parental history of type 2 diabetes, raising the possibility of an inheritable etiology (Petersen et al., 2004).”
BackgroundZhang, D., Christianson, J., Liu, Z.-X., Tian, L., Choi, C. S., Neschen, S., Dong, J., Wood, P. A., & Shulman, G. I. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.012 · Cited by 84
“Mitochondrial dysfunction with impaired skeletal muscle oxidative phosphorylation has been implicated in the pathogenesis of insulin resistance and type 2 diabetes mellitus (T2DM) (Kelley et al., 2002; Petersen et al., 2003; Mootha et al., 2003; Patti et al., 2003; Petersen et al., 2004).”
BackgroundSelf-citationMuller, C. J. F., Malherbe, C. J., Chellan, N., Yagasaki, K., Miura, Y., & Joubert, E. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1157568 · Cited by 91
“The increase of intramyocellular FFA metabolites and associated lipotoxic mitochondrial dysfunction cause impaired fat oxidation and a decrease in metabolic flux through the tricarboxylic acid cycle (Petersen et al., 2004).”
BackgroundMitochondrial dysfunction and type 2 diabetes
Parish, R., & Petersen, K. F. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0006-3 · Cited by 96
Self-citation
Metadata
- Authors
- Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-12
- Volume
- 350
- Issue
- 7
- Pages
- 664-671
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2995502
- OpenAlex
- W2027670788
- Cited by
- 2,193
- References
- 44
- Citations by year
- 2026: 38 · 2025: 38 · 2024: 51 · 2023: 71 · 2022: 47 · 2021: 75 · 2020: 87 · 2019: 59 · 2018: 84 · 2017: 87 · 2016: 87 · 2015: 88 · 2014: 97 · 2013: 113 · 2012: 122
- FWCI
- 101.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01-AG-23686, R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK063192, P30DK45735, R01DK049230, R01 DK-49230, K-23 DK-02347, P30DK045735)
- National Center for Research Resources (M01RR000125, M01 RR-00125)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, offspring of diabetic patients, mitochondrial dysfunction, oxidative phosphorylation, skeletal muscle glucose uptake, intramyocellular lipid, fatty acid metabolism, hepatic insulin sensitivity, glycerol turnover, 31P NMR, 1H NMR, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Female, Glucose, Glucose Tolerance Test, Glycerol, Humans, Insulin, Insulin Resistance, Lipolysis, Male, Mitochondria, Magnetic Resonance Spectroscopy, Oxidative Phosphorylation, Triglycerides, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.